In-silico study of some natural compounds used as antifungal agents against Candida albicans
Abstract
Fungal diseases are very common these days, so there is a high need to design and develop new antifungal drugs that can counter these diseases. Candida albicans is one of the opportunistic pathogenic yeasts that can cause serious diseases such as oropharyngeal candidiasis, vulvovaginal (genital) candidiasis, and invasive candidiasis (candidemia). This article focuses on the in-silico evaluation of anti-candidal activity of some natural compounds like ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-Shogaol. Binding affinity of these compounds have been determined against the most common targets in C. albicans viz. cytochrome p450, lanosterol synthase, serine/threonine protein kinase, squalene monooxygenase, sterol-14-demethylase and thymidylate synthase. PatchDock and FireDock web servers were used to carry out the docking studies. The proposed targets of ajoene, allicin, curcumin, gingerol, nimbin, nimbolide, nimonol and 6-Shogaol are sterol 14-demethylase, cytochrome p450, cytochrome p450, cytochrome p450, cytochrome p450, squalene monooxygenase, lanosterol synthase and squalene monooxygenase respectively based upon the binding energies obtained by the docking studies. This study opens new avenues in the usage of the natural compounds as potential antifungal agents.
Downloads
References
2. Kourkoumpetis TK, Velmahos GC, Ziakas PD, Tampakakis E, Manolakaki D, Coleman JJ, Mylonakis E. The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients. Mycopathologia. 2011; 171: 85-91.
3. Saltarelli CG. Candida albicans: The pathogenic fungus. New York: Hemisphere Publishing Corporation; 1989.
4. Fu XH, Meng FL, Hu Y, Zhou JQ. Candida albicans, a distinctive fungal model for cellular aging study. Aging cell. 2008; 7(5): 746-757.
5. Lewis RE. Current concepts in antifungal pharmacology. Mayo Clinic Proceed. 2011; 86: 805-817.
6. Mahmoud DA, Hassanein NM, Youssef KA, Zeid A. Antifungal activity of different neem leaf extracts and the nimonol against some important human pathogens. Braz J Microbiol. 2011; 42: 1007-1016.
7. Kim YS, Kim KS, Han I, Kim MH, Jung MH, Park HK. Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugs. PLoS One. 2012; 7(6): e38242.
8. Yoshida S, Kasuga S, Hayashi NO, Ushiroguchi T, Matsuura H, Nakagawa S. Antifungal activity of ajoene derived from garlic. Appl Environ Microbiol. 1987; 53: 615-617.
9. Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res Int. 2014; 2014: 186864.
10. Lee JH, Kim YG, Choi P, Ham J, Park JG, Lee J. Antibiofilm and antivirulence activities of 6-gingerol and 6-shogaol against Candida albicans due to hyphal inhibition. Front Cell Infect Microbiol. 2018; 8: 299.
11. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols. 2015;1 0: 845.
12. Babel O. An open chemical toolbox. J Cheminform. 2011; 3: 33.
13. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005; 33: W363-367.
14. Andrusier N, Nussinov R, Wolfson HJ. FireDock: fast interaction refinement in molecular docking. Proteins Struct Function Bioinform. 2007; 69: 139-159.
15. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera - a visualization system for exploratory research and analysis. J Computat Chem. 2004; 25: 1605-1612.
16. Lovell SC, Davis IW, Arendall WB, de Bakker PI, Word JM, Prisant MG, et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins. 2003; 50: 437-450.
17. Ghannoum MA. Candida: a causative agent of an emerging infection. J Investig Dermatol Symp Proceed. 2001; 6: 188-196.
18. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases - estimate precision. J Fungi. 2017; 3: 57.
19. Yang CW, Barkham TM, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol. 2003; 41: 472-474.
20. Murugesh J, Annigeri RG, Mangala GK, Mythily PH, Chandrakala J. Evaluation of the antifungal efficacy of different concentrations of Curcuma longa on Candida albicans: An in vitro study. J Oral Maxillofacial Pathol. 2019; 23: 305.
21. Chen E, Benso B, Seleem D, Ferreira LE, Pasetto S, Pardi V, Murata RM. Fungal-host interaction: curcumin modulates proteolytic enzyme activity of Candida albicans and inflammatory host response in vitro. Int J Dent. 2018; 2018: ID 2393146.
22. Thakre AD, Mulange SV, Kodgire SS, Zore GB, Karuppayil SM. Effects of cinnamaldehyde, ocimene, camphene, curcumin and farnesene on Candida albicans. Adv Microbiol. 2016; 6: 627-643.
23. Santos VR, Pereira EM. Antifungal activity of Brazilian medicinal plants against Candida species. In: Candida albicans. IntechOpen, 2018.
24. Khodavandi A, Alizadeh F, Aala F, Sekawi Z, Chong PP. In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species. Mycopathologia. 2010; 169: 287-295.
25. Bansal V, Gupta M, Bhaduri T, Shaikh SA, Sayed FR, Bansal V, Agrawal A. Assessment of antimicrobial effectiveness of neem and clove extract against Streptococcus mutans and Candida albicans: an in vitro study. Nigerian Med J. 2019; 60: 285.
26. Kandhan TS, Geetha RV. Antimycotic activity of Zingiber officinale extracts on clinical isolates of Candida albicans. Drug Invention Today. 2018; 10(12): 2546-2549.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
